Literature for captopril (XM02.001)

(Topics flags: S Structure, A Assay, I Inhibitor, E Expression. To select only the references relevant to a single topic, click the link above. See explanation.)

2018
1. Chan,G.C.W., Wu,H.J., Chan,K.W., Yiu,W.H., Zou,A., Huang,X.R., Lan,H.Y., Lai,K.N. and Tang,S.C.W.
   N-Acetyl-seryl-aspartyl-lysyl-proline mediates the anti-fibrotic properties of captopril in unilateral ureteric obstructed BALB/C mice
   Nephrology (Carlton)23, 297-307. PubMed  Europe PubMed DOI  I
2016
2. Kumar,S., Dietrich,N. and Kornfeld,K.
   Angiotensin converting enzyme (ACE) inhibitor extends Caenorhabditis elegans life span
   PLoS Genet12, e1005866-e1005866. PubMed  Europe PubMed DOI  I
2014
3. Flores-Monroy,J., Ferrario,C.M., Valencia-Hernandez,I., Hernandez-Campos,M.E. and Martinez-Aguilar,L.
   Comparative effects of a novel angiotensin-converting enzyme inhibitor versus captopril on plasma angiotensins after myocardial infarction
   Pharmacology94, 21-28. PubMed  Europe PubMed DOI  I
4. Kuntze,L.B., Antonio,R.C., Izidoro-Toledo,T.C., Meschiari,C.A., Tanus-Santos,J.E. and Gerlach,R.F.
   Captopril and lisinopril only inhibit matrix metalloproteinase-2 (MMP-2) activity at millimolar concentrations
   Basic Clin Pharmacol Toxicol114, 233-239. PubMed  Europe PubMed DOI  I
2013
5. Chen,J., Wang,Y., Ye,R., Wu,Y. and Xia,W.
   Comparison of analytical methods to assay inhibitors of angiotensin I-converting enzyme
   Food Chem141, 3329-3334. PubMed  Europe PubMed DOI  A  I
2011
6. Akif,M., Masuyer,G., Schwager,S.L., Bhuyan,B.J., Mugesh,G., Isaac,R.E., Sturrock,E.D. and Acharya,K.R.
   Structural characterization of angiotensin I-converting enzyme in complex with a selenium analogue of captopril
   FEBS J278, 3644-3650. PubMed  Europe PubMed DOI  S  I
7. Bhuyan,B.J. and Mugesh,G.
   Effect of peptide-based captopril analogues on angiotensin converting enzyme activity and peroxynitrite-mediated tyrosine nitration
   Org Biomol Chem9, 5185-5192. PubMed  Europe PubMed DOI  I
2006
8. [YEAR:1-8-2006]Tzakos,A.G., Naqvi,N., Comporozos,K., Pierattelli,R., Theodorou,V., Husain,A. and Gerothanassis,I.P.
   The molecular basis for the selection of captopril cis and trans conformations by angiotensin I converting enzyme
   Bioorg Med Chem Lett16, 5084-5087. PubMed  Europe PubMed DOI  I
2005
9. Li,G.H., Liu,H., Shi,Y.H. and Le,G.W.
   Direct spectrophotometric measurement of angiotensin I-converting enzyme inhibitory activity for screening bioactive peptides
   J Pharm Biomed Anal37, 219-224. PubMed  Europe PubMed DOI  A  I
2004
10. [YEAR:1-3-2004]Kruse,M.N., Becker,C., Lottaz,D., Kohler,D., Yiallouros,I., Krell,H.W., Sterchi,E.E. and Stocker,W.
    Human meprin alpha and beta homo-oligomers: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors
    Biochem J378, 383-389. PubMed  Europe PubMed DOI  I
11. [YEAR:13-7-2004]Natesh,R., Schwager,S.L., Evans,H.R., Sturrock,E.D. and Acharya,K.R.
    Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme
    Biochemistry43, 8718-8724. PubMed  Europe PubMed DOI  S  I
2003
12. [YEAR:28-8-2003]Binevski,P.V., Sizova,E.A., Pozdnev,V.F. and Kost,O.A.
    Evidence for the negative cooperativity of the two active sites within bovine somatic angiotensin-converting enzyme
    FEBS Lett550, 84-88. PubMed  Europe PubMed DOI  I
13. [YEAR:13-3-2003]Kim,H.M., Shin,D.R., Yoo,O.J., Lee,H. and Lee,J.O.
    Crystal structure of Drosophila angiotensin I-converting enzyme bound to captopril and lisinopril
    FEBS Lett538, 65-70. PubMed  Europe PubMed DOI  S  I
2002
14. Thunnissen,M.M., Andersson,B., Samuelsson,B., Wong,C.H. and Haeggstrom,J.Z.
    Crystal structures of leukotriene A4 hydrolase in complex with captopril and two competitive tight-binding inhibitors
    FASEB J16, 1648-1650. PubMed  Europe PubMed DOI  S  I
2000
15. [YEAR:1-9-2000]Donoghue,M., Hsieh,F., Baronas,E., Godbout,K., Gosselin,M., Stagliano,N., Donovan,M., Woolf,B., Robison,K., Jeyaseelan,R., Breitbart,R.E. and Acton,S.
    A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9
    Circ Res87, E1-E9. PubMed  Europe PubMed  I
16. [YEAR:27-10-2000]Tipnis,S.R., Hooper,N.M., Hyde,R., Karran,E., Christie,G. and Turner,A.J.
    A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase
    J Biol Chem275, 33238-33243. PubMed  Europe PubMed DOI  E  I
1999
17. Junot,C., Menard,J., Gonzales,M.F., Michaud,A., Corvol,P. and Ezan,E.
    In vivo assessment of captopril selectivity of angiotensin I-converting enzyme inhibition: differential inhibition of acetyl-Ser-Asp-Lys-Pro and angiotensin I hydrolysis
    J Pharmacol Exp Ther289, 1257-1261. PubMed  Europe PubMed  I
1998
18. Houard,X., Williams,T.A., Michaud,A., Dani,P., Isaac,R.E., Shirras,A.D., Coates,D. and Corvol,P.
    The Drosophila melanogaster-related angiotensin-I-converting enzymes Acer and Ance - distinct enzymic characteristics and alternative expression during pupal development
    Eur J Biochem257, 599-606. PubMed  Europe PubMed  I
1997
19. Michaud,A., Williams,T.A., Chauvet,M.T. and Corvol,P.
    Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I
    Mol Pharmacol51, 1070-1076. PubMed  Europe PubMed  I
1996
20. Bevilacqua,M., Vago,T., Rogolino,A., Conci,F., Santoli,E. and Norbiato,G.
    Affinity of angiotensin I-converting enzyme (ACE) inhibitors for N- and C-binding sites of human ACE is different in heart, lung, arteries, and veins
    J Cardiovasc Pharmacol28, 494-499. PubMed  Europe PubMed DOI  I
1992
21. [YEAR:5-7-1992]Wei,L., Clauser,E., Alhenc-Gelas,F. and Corvol,P.
    The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors
    J Biol Chem267, 13398-13405. PubMed  Europe PubMed  I
1985
22. Ganapathy,V., Pashley,S.J., Roesel,R.A., Pashley,D.H. and Leibach,F.H.
    Inhibition of rat and human prolidases by captopril
    Biochem Pharmacol34, 1287-1291. PubMed  Europe PubMed DOI  I
1984
23. Bunning,P.
    Inhibition of angiotensin converting enzyme by 2-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498 diacid). Comparison with captopril and enalaprilat
    Arzneimittelforschung34, 1406-1410. PubMed  Europe PubMed  I
24. [YEAR:15-4-1984]Reynolds,C.H.
    Kinetics of inhibition of angiotensin converting enzyme by captopril and by enalapril diacid
    Biochem Pharmacol33, 1273-1276. PubMed  Europe PubMed DOI  I
25. [YEAR:23-10-1984]Shapiro,R. and Riordan,J.F.
    Inhibition of angiotensin converting enzyme: mechanism and substrate dependence
    Biochemistry23, 5225-5233. PubMed  Europe PubMed  I
26. [YEAR:23-10-1984]Shapiro,R. and Riordan,J.F.
    Inhibition of angiotensin converting enzyme: dependence on chloride
    Biochemistry23, 5234-5240. PubMed  Europe PubMed  I
27. Strittmatter,S.M., Lo,M.M., Javitch,J.A. and Snyder,S.H.
    Autoradiographic visualization of angiotensin-converting enzyme in rat brain with [3H]captopril: localization to a striatonigral pathway
    Proc Natl Acad Sci U S A81, 1599-1603. PubMed  Europe PubMed  I
1981
28. Boomsma,F., de Bruyn,J.H., Derkx,F.H. and Schalekamp,M.A.
    Opposite effects of captopril on angiotensin I-converting enzyme 'activity' and 'concentration'; relation between enzyme inhibition and long-term blood pressure response
    Clin Sci (Lond)60, 491-498. PubMed  Europe PubMed  I
1978
29. Deutch,C.E. and Soffer,R.L.
    Escherichia coli mutants defective in dipeptidyl carboxypeptidase
    Proc Natl Acad Sci U S A75, 5998-6001. PubMed  Europe PubMed  I
1977
30. [YEAR:13-12-1977]Cushman,D.W., Cheung,H.S., Sabo,E.F. and Ondetti,M.A.
    Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids
    Biochemistry16, 5484-5491. PubMed  Europe PubMed DOI  I